Precision medicine has been limited by technological, ethical, and regulatory challenges, but agile governance could harness it for the public good.
Biden has relaunched the Cancer Moonshot project – pledging to cut cancer deaths in half by 2047. Technology, along with widening access to care, will be key.
The low COVID-19 death rate in Japan could be a result of gut microbes, new research reveals - and the discovery could pave the way for a new treatment.
A man in the US, suffering from heart disease became the first person ever to receive a transplant from a genetically modified pig heart this year.
Rapid antigen tests are now more accessible than ever in supermarkets and pharmacies, so it is important that everyone knows how to use them correctly.
An ideal bioeconomy policy agenda needs to be established so that everyone can benefit from the latest advancements made in synthetic biology, expert says.
Precision medicine needs financing to fight diseases like cancer. Non-communicable diseases such as cancer and heart disease are an increasing problem in poor countries, but development f...
Gene therapies can cure incurable diseases, such as sickle cell disease, but treatment costs and lack of in-country manufacturing are slowing progress.
There is potential for genetic engineering to bolster the response to climate change, but there are also risks and unknowns.
Gene therapies can cost million of dollars. Kevin Doxzen explains why creative new payment systems are needed to help fund treatment.
The World Health Organization has called for a moratorium on COVID-19 vaccine booster shots, to enable low-income countries to get more people vaccinated.
Researchers at Yale have developed ways to effectively map variations in individual symptoms to mental illnesses, such as major depression, schizophrenia, or anxiety.
The natural world is an important source of medicines. PCR tests for COVID-19 are only effective due to a bacteria discovered in the Yellowstone National Park.
The virus that causes COVID-19 is mutating constantly, and often these changes have little impact. The WHO is currently tracking variants of concern.